If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. However, after briefly looking over the numbers, we don't think Naba Al Saha Medical Services (TADAWUL:9546) has the makings of a multi-bagger going forward, but let's have a look at why that may be.

Understanding Return On Capital Employed (ROCE)

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. The formula for this calculation on Naba Al Saha Medical Services is:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.079 = ر.س25m ÷ (ر.س340m - ر.س26m) (Based on the trailing twelve months to June 2025).

So, Naba Al Saha Medical Services has an ROCE of 7.9%. Ultimately, that's a low return and it under-performs the Healthcare industry average of 14%.

Historical performance is a great place to start when researching a stock so above you can see the gauge for Naba Al Saha Medical Services' ROCE against it's prior returns. If you want to delve into the historical earnings , check out these free graphs detailing revenue and cash flow performance of Naba Al Saha Medical Services.

What Can We Tell From Naba Al Saha Medical Services' ROCE Trend?

When we looked at the ROCE trend at Naba Al Saha Medical Services, we didn't gain much confidence. Over the last four years, returns on capital have decreased to 7.9% from 22% four years ago. Meanwhile, the business is utilizing more capital but this hasn't moved the needle much in terms of sales in the past 12 months, so this could reflect longer term investments. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line.

The Bottom Line On Naba Al Saha Medical Services' ROCE

In summary, Naba Al Saha Medical Services is reinvesting funds back into the business for growth but unfortunately it looks like sales haven't increased much just yet. Although the market must be expecting these trends to improve because the stock has gained 72% over the last three years. But if the trajectory of these underlying trends continue, we think the likelihood of it being a multi-bagger from here isn't high.

If you want to know some of the risks facing Naba Al Saha Medical Services we've found 3 warning signs (2 can't be ignored!) that you should be aware of before investing here.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.